Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids and appetite: Food craving and food pleasure
Tim C. Kirkham
International Review of Psychiatry (2009) Vol. 21, Iss. 2, pp. 163-171
Closed Access | Times Cited: 176

Showing 1-25 of 176 citing articles:

Anti-obesity drugs: past, present and future
R.J. Rodgers, Matthias H. Tschöp, John Wilding
Disease Models & Mechanisms (2012) Vol. 5, Iss. 5, pp. 621-626
Open Access | Times Cited: 418
CB1 Cannabinoid Receptors and their Associated Proteins
A­llyn C. Howlett, Lawrence C. Blume, George D. Dalton
Current Medicinal Chemistry (2010) Vol. 17, Iss. 14, pp. 1382-1393
Open Access | Times Cited: 270
Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
Celia J. A. Morgan, Tom P. Freeman, Gráinne Schäfer, et al.
Neuropsychopharmacology (2010) Vol. 35, Iss. 9, pp. 1879-1885
Open Access | Times Cited: 190
Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders
Javier Fernández‐Ruíz, Mariluz Hernández, J.A. Ramos
CNS Neuroscience & Therapeutics (2010) Vol. 16, Iss. 3
Open Access | Times Cited: 154
Lipids in psychiatric disorders and preventive medicine
Miriam Schneider, Beth Levant, Martin Reichel, et al.
Neuroscience & Biobehavioral Reviews (2016) Vol. 76, pp. 336-362
Open Access | Times Cited: 151
The Antimicrobial Activity of Cannabinoids
John A. Karas, Labell J. M. Wong, Olivia K. A. Paulin, et al.
Antibiotics (2020) Vol. 9, Iss. 7, pp. 406-406
Open Access | Times Cited: 99
Cannabinoid–dopamine interactions in the physiology and physiopathology of the basal ganglia
Concepción García, Cristina Palomo‐Garo, Yolanda Gómez‐Gálvez, et al.
British Journal of Pharmacology (2015) Vol. 173, Iss. 13, pp. 2069-2079
Open Access | Times Cited: 94
A prospective open‐label trial of a CBD/THC cannabis oil in dravet syndrome
Bláthnaid McCoy, Laura Wang, Maria Zak, et al.
Annals of Clinical and Translational Neurology (2018) Vol. 5, Iss. 9, pp. 1077-1088
Open Access | Times Cited: 94
Mechanisms of weight regain.
Luca Busetto, Silvia Bettini, Janine Makaronidis, et al.
European Journal of Internal Medicine (2021) Vol. 93, pp. 3-7
Open Access | Times Cited: 93
Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits
Benjamin K. Lau, Daniela Cota, Luigia Cristino, et al.
Neuropharmacology (2017) Vol. 124, pp. 38-51
Closed Access | Times Cited: 90
Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists
Elise Wouters, Jolien Walraed, Samuel D. Banister, et al.
Biochemical Pharmacology (2019) Vol. 169, pp. 113623-113623
Closed Access | Times Cited: 79
Molecular mechanisms underlying anorexia nervosa: Focus on human gene association studies and systems controlling food intake
Mathias Rask‐Andersen, Pawel K. Olszewski, Allen S. Levine, et al.
Brain Research Reviews (2009) Vol. 62, Iss. 2, pp. 147-164
Closed Access | Times Cited: 113
Hedonic and motivational roles of opioids in food reward: Implications for overeating disorders
Susana Peciña, Kyle S. Smith
Pharmacology Biochemistry and Behavior (2010) Vol. 97, Iss. 1, pp. 34-46
Closed Access | Times Cited: 102
2-Arachidonoylglycerol Signaling in Forebrain Regulates Systemic Energy Metabolism
Kwang‐Mook Jung, Jason R. Clapper, Jin Fu, et al.
Cell Metabolism (2012) Vol. 15, Iss. 3, pp. 299-310
Open Access | Times Cited: 100
Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain
Katrina Weston‐Green, Xu‐Feng Huang, Chao Deng
PLoS ONE (2012) Vol. 7, Iss. 3, pp. e33548-e33548
Open Access | Times Cited: 90
Dissecting the cannabinergic control of behavior: The where matters
Arnau Busquets‐Garcia, Tifany Desprez, Mathilde Metna‐Laurent, et al.
BioEssays (2015) Vol. 37, Iss. 11, pp. 1215-1225
Closed Access | Times Cited: 87
Effects Of A Post-Weaning Cafeteria Diet In Young Rats: Metabolic Syndrome, Reduced Activity And Low Anxiety-Like Behaviour
Jaume F. Lalanza, Antoni Caimari, Josep M Del Bas-Prior, et al.
PLoS ONE (2014) Vol. 9, Iss. 1, pp. e85049-e85049
Open Access | Times Cited: 85
The Effect of Medical Marijuana Laws on Body Weight
Joseph J. Sabia, Jeffrey Swigert, Timothy Christopher Young
Health Economics (2015) Vol. 26, Iss. 1, pp. 6-34
Closed Access | Times Cited: 84
A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women
Antoni Pastor, Fernando Fernández‐Aranda, Montserrat Fitó, et al.
PLoS ONE (2016) Vol. 11, Iss. 2, pp. e0148734-e0148734
Open Access | Times Cited: 78
Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders
Cristoforo Silvestri, Vincenzo Di Marzo
Expert Opinion on Investigational Drugs (2012) Vol. 21, Iss. 9, pp. 1309-1322
Closed Access | Times Cited: 76
Heavy Cannabis Use Is Associated With Low Bone Mineral Density and an Increased Risk of Fractures
Antonia Sophocleous, Roy Robertson, Nuno Ferreira, et al.
The American Journal of Medicine (2016) Vol. 130, Iss. 2, pp. 214-221
Open Access | Times Cited: 69
Ghrelin and food reward
Omar Al–Massadi, Rubén Nogueiras, Carlos Diéguez, et al.
Neuropharmacology (2019) Vol. 148, pp. 131-138
Open Access | Times Cited: 67
Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study
Mehdi Farokhnia, Gray R. McDiarmid, Matthew N. Newmeyer, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 62
Efficacy of medicinal cannabis for appetite-related symptoms in people with cancer: A systematic review
Valentina Razmovski‐Naumovski, Tim Luckett, Ingrid Amgarth‐Duff, et al.
Palliative Medicine (2022) Vol. 36, Iss. 6, pp. 912-927
Closed Access | Times Cited: 29
The Peptide Hemopressin Acts through CB1Cannabinoid Receptors to Reduce Food Intake in Rats and Mice
Garron T. Dodd, Giacomo Mancini, Beat Lutz, et al.
Journal of Neuroscience (2010) Vol. 30, Iss. 21, pp. 7369-7376
Open Access | Times Cited: 81
Page 1 - Next Page

Scroll to top